Company news

GeneDx Holdings Corp. news in 2025

GeneDx Holdings Corp.'s news releases, calls and decks from 2025, newest first.

View company

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

December 29, 2025

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

December 14, 2025

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

November 5, 2025

GeneDx to Participate in Upcoming Investor Conferences

November 3, 2025

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

October 27, 2025

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

October 21, 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

October 19, 2025

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

October 13, 2025

GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program

October 12, 2025

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

October 8, 2025

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

October 7, 2025

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

October 6, 2025

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

September 30, 2025

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

September 29, 2025

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

September 24, 2025

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

September 17, 2025

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

July 28, 2025

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

July 9, 2025

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

June 24, 2025

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

June 22, 2025

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

May 21, 2025

GeneDx Announces Completion of Fabric Genomics Acquisition

May 6, 2025

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

April 29, 2025

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

April 15, 2025

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

April 7, 2025

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

April 2, 2025

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 19, 2025

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

March 17, 2025

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

March 12, 2025

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

March 12, 2025

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

March 3, 2025

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

February 23, 2025

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

February 17, 2025

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

February 12, 2025

GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

February 11, 2025

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment

February 9, 2025

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

January 27, 2025

GeneDx Announces Preliminary 2024 Financial Results

January 12, 2025

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

January 8, 2025

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

January 7, 2025

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer

January 1, 2025

Calls in 2025

Decks in 2025